Eileen M. Rogan

1.4k total citations
12 papers, 1.1k citations indexed

About

Eileen M. Rogan is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Eileen M. Rogan has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Eileen M. Rogan's work include Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (2 papers) and Viral Infections and Immunology Research (1 paper). Eileen M. Rogan is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (2 papers) and Viral Infections and Immunology Research (1 paper). Eileen M. Rogan collaborates with scholars based in Australia, United States and Germany. Eileen M. Rogan's co-authors include Owen W.J. Prall, Robert L. Sutherland, Elizabeth A. Musgrove, Colin K. W. Watts, Roger R. Reddel, Curtis C. Harris, Norbert E. Fusenig, Teresa A. Lehman, Robert A. Metcalf and Martha R. Stampfer and has published in prestigious journals such as Molecular and Cellular Biology, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

Eileen M. Rogan

12 papers receiving 1.1k citations

Peers

Eileen M. Rogan
Floyd M. Price United States
Michael J. Antinore United States
Jennifer D. Luethy United States
Chitra Chandrasekaran United States
H U Kontny United States
Sarah Gledhill United Kingdom
Floyd M. Price United States
Eileen M. Rogan
Citations per year, relative to Eileen M. Rogan Eileen M. Rogan (= 1×) peers Floyd M. Price

Countries citing papers authored by Eileen M. Rogan

Since Specialization
Citations

This map shows the geographic impact of Eileen M. Rogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen M. Rogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen M. Rogan more than expected).

Fields of papers citing papers by Eileen M. Rogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen M. Rogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen M. Rogan. The network helps show where Eileen M. Rogan may publish in the future.

Co-authorship network of co-authors of Eileen M. Rogan

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen M. Rogan. A scholar is included among the top collaborators of Eileen M. Rogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen M. Rogan. Eileen M. Rogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rogan, Eileen M.. (2023). Medical leadership and management: What's in it for FACEM trainees?. Emergency Medicine Australasia. 35(4). 685–686. 2 indexed citations
3.
Prall, Owen W.J., Eileen M. Rogan, & Robert L. Sutherland. (1998). Estrogen regulation of cell cycle progression in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 65(1-6). 169–174. 131 indexed citations
4.
Prall, Owen W.J., Eileen M. Rogan, Elizabeth A. Musgrove, Colin K. W. Watts, & Robert L. Sutherland. (1998). c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry. Molecular and Cellular Biology. 18(8). 4499–4508. 219 indexed citations
5.
Noble, Jane R., et al.. (1996). Association of extended in vitro proliferative potential with loss of p16INK4 expression.. PubMed. 13(6). 1259–68. 49 indexed citations
6.
Rogan, Eileen M., Tracy M. Bryan, Bharati Hukku, et al.. (1995). Alterations in p53 and p16 INK4 Expression and Telomere Length during Spontaneous Immortalization of Li-Fraumeni Syndrome Fibroblasts. Molecular and Cellular Biology. 15(9). 4745–4753. 211 indexed citations
7.
Duncan, Emma L., Eileen M. Rogan, Noel J. Whitaker, et al.. (1995). Sv40‐induced immortalization and ras‐transformation of human bronchial epithelial cells. International Journal of Cancer. 61(2). 199–205. 39 indexed citations
8.
Whitaker, Noel J., et al.. (1994). HPV-16 E6 and E7 Genes, like SV40 Early Region Genes, Are Insufficient for Immortalization of Human Mesothelial and Bronchial Epithelial Cells. Experimental Cell Research. 213(2). 418–427. 21 indexed citations
9.
Maclean, Kenneth N., Eileen M. Rogan, Noel J. Whitaker, et al.. (1994). In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants.. PubMed. 9(3). 719–25. 17 indexed citations
10.
Lehman, Teresa A., Ramakrishna Modali, Petra Boukamp, et al.. (1993). Errata: p53 Mutations in human immortalized epithelial cell lines (Carcinogenesis (1993) 14 (833-839)). Carcinogenesis. 14(7). 40 indexed citations
11.
Lehman, Teresa A., Rama Modali, Petra Boukamp, et al.. (1993). p53 Mutations in human immortalized epithelial cell lines. Carcinogenesis. 14(5). 833–839. 375 indexed citations
12.
Kirkland, PD, et al.. (1990). The impact of pestivirus on an artificial breeding program for cattle. Australian Veterinary Journal. 67(7). 261–263. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026